IRIS
NOBILI, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.929
NA - Nord America 3.396
AS - Asia 2.512
SA - Sud America 400
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 10.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.354
RU - Federazione Russa 1.256
SG - Singapore 909
IE - Irlanda 783
CN - Cina 742
UA - Ucraina 465
HK - Hong Kong 397
GB - Regno Unito 369
BR - Brasile 347
IT - Italia 303
DE - Germania 272
SE - Svezia 153
FI - Finlandia 124
IN - India 115
TR - Turchia 102
FR - Francia 79
GR - Grecia 69
KR - Corea 57
VN - Vietnam 57
JP - Giappone 54
AR - Argentina 23
CA - Canada 21
BE - Belgio 20
BD - Bangladesh 15
MX - Messico 11
CZ - Repubblica Ceca 9
IQ - Iraq 9
EC - Ecuador 8
SA - Arabia Saudita 8
ZA - Sudafrica 8
NL - Olanda 7
CO - Colombia 6
IR - Iran 6
PY - Paraguay 6
EU - Europa 5
PH - Filippine 5
PL - Polonia 5
UZ - Uzbekistan 5
ID - Indonesia 4
KZ - Kazakistan 4
PK - Pakistan 4
TN - Tunisia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ES - Italia 3
GE - Georgia 3
PT - Portogallo 3
CR - Costa Rica 2
EG - Egitto 2
IS - Islanda 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
GT - Guatemala 1
HN - Honduras 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 10.268
Salva come PNG Salva come JPEG
Città #
Dublin 782
Jacksonville 692
Chandler 596
Moscow 403
Hong Kong 392
Santa Clara 353
Singapore 329
Ann Arbor 125
Princeton 120
Medford 111
Boardman 104
Bengaluru 103
Hefei 98
Beijing 97
San Mateo 87
Wilmington 78
Ashburn 74
Caserta 69
Woodbridge 69
Dallas 65
Nanjing 62
Seoul 56
Bremen 48
Munich 31
Cambridge 30
New York 29
Roxbury 29
The Dalles 27
Ho Chi Minh City 24
São Paulo 24
Dearborn 21
Düsseldorf 21
Brussels 20
Istanbul 20
Kunming 20
Jinan 19
Guangzhou 16
Mountain View 16
Napoli 15
Des Moines 14
Grumo Nevano 13
Nanchang 13
Auburn Hills 12
Belo Horizonte 12
Naples 12
Tianjin 12
Curitiba 11
Los Angeles 11
Norwalk 11
Rio de Janeiro 11
Zhengzhou 11
Elora 9
Hangzhou 9
Hanoi 9
Milan 8
Shenyang 8
Brno 7
Hebei 7
Helsinki 7
Atlanta 6
Chicago 6
Houston 6
Ningbo 6
Redwood City 6
Riyadh 6
Shanghai 6
Frankfurt am Main 5
Johannesburg 5
Lanzhou 5
Nocera Inferiore 5
Porto Alegre 5
Tashkent 5
Amsterdam 4
Baghdad 4
Brasília 4
Campinas 4
Centrale 4
Changchun 4
Changsha 4
Cutrofiano 4
Dhaka 4
Falls Church 4
Goiânia 4
Jiaxing 4
London 4
Recife 4
Ribeirão Preto 4
Rio Grande 4
Santo André 4
Seattle 4
Taiyuan 4
Verona 4
Warsaw 4
Asunción 3
Boston 3
Cape Town 3
Caracas 3
Cava 3
Central 3
Chapecó 3
Totale 5.659
Salva come PNG Salva come JPEG
Nome #
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. 175
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis 171
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 161
Cannabinoid receptor 2 Q63R variant could modulate the relationship between childhood obesity and age at menarche 135
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 135
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification 135
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 134
Ematologia 133
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 126
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 126
A case of cutaneous mastocytosis associated with A-G dysgammaglobulinemia 119
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 119
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression. 117
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity 116
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 114
[Sanfilippo's disease of type B. Study of the enzymatic deficiency in a family] 112
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties. 111
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. 109
The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. 107
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties. 105
The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice. 103
Vitamin A and infancy. Biochemical, functional, and clinical aspects 103
A modification of the 'pink test' may improve the diagnosis of hereditary spherocytosis 103
Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1 103
Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q 102
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function 102
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 102
[Antibiotic therapy: cephalosporins] 102
Vitamin A and infancy. Biochemical, functional, and clinical aspects 101
The 17-estradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression 99
Interaction between metabotropic and NMDA glutamate receptors participate in the periaqueductal grey pain modulatory system 98
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. 98
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity 97
[Fluorimetric determination of erythrocytic free protoporphyrins in evaluation of iron deficiency states] 96
[Alpha thalassemia in Campania: results of a survey of 319 newborn infants] 96
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 95
[A case of progeria associated with Uhl's syndrome] 95
Spectrum of FANCA mutations in Italian Fanconi anemia patients: identification of six novel alleles and phenotypic characterization of the S858R variant 94
[Current possibilities of the use of ferritin in clinical diagnosis] 94
Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency 93
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition 93
Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency 93
[The L-dopa test in diagnosis of pituitary dwarfism] 92
[Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)] 91
[Diagnostic methods in iron deficiency states. Comparative data on free protoporphyrins of erythrocytes in iron deficiency states and in thalassemia] 91
Effects of nebivolol on human platelet aggregation 90
[Glycerol test in thalassemia diagnosis (author's transl)] 90
[Hematological screening of a group of children from a school population] 90
Studio retrospettivo sulle complicanze emato-oncologiche nella neurofibromatosi tipo 1 in età pediatrica 90
[An unusual salt-losing syndrome: pseudohypoaldosteronism. Description of a case] 89
Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis 88
[Prevention therapy of infections in the course of granulocytopenia] 88
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study 86
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura 86
Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele 85
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience 85
[Problems of antibiotic therapy in pediatrics] 84
The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption 84
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 83
[Cartilage-hair hypoplasia: clinical and immunological study] 83
L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients 82
ROBO2 gene variants are associated with familial vesicoureteral reflux 81
Spectrin/band 3 ratio as diagnostic tool in hereditary spherocytosis 81
[Fetal hemoglobin during the first year of life: evaluation of total erythrocytes, neocytes and gerocytes] 81
[Very unusual combination: congenital nephrosis and bilateral congenital glaucoma] 80
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 79
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 78
Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis 78
Hereditary spherocytosis due to a novel frameshift mutation in AE1 cytoplasmic COOH terminal tail: band 3 Vesuvio 78
COINHERITANCE OF GILBERT SYNDROME INCREASES THE RISK FOR DEVELOPING GALLSTONES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS 77
Serum Hepcidin and Iron Absorption in Pediatric Inflammatory Bowel Disease. 77
The DMT1 IVS4+44C>A polymorphism and the risk of iron deficiency anemia in children with celiac disease 77
Reversible erythrocyte skeleton destabilization is modulated by beta-spectrin phosphorylation in childhood leukemia 76
Le anemie diseritropoietiche 76
La prevenzione dell’anemia mediterranea in Campania: stato attuale e prospettive 76
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 76
Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis 75
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation 75
Diamond-Blackfan anaemia in the Italian population 75
Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus 75
[Prenatal diagnosis: current knowledge and future prospects] 75
Bart's hemoglobin in newborn infants of Campania 75
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 75
REPORT OF ADVERSE TRANSFUSION REACTIONS: EMOCOMPONENTS VIA APHERESIS VS WHOLE BLOOD INPEDIATRIC PATIENTS 75
Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II) 74
Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia 74
Erythropoietin treatment can prevent blood transfusion in infantile pyknocytosis 73
ROBO2 gene variants are associated with familial vesicouretral reflux 73
Rituximab for the treatment of refractory autoimmune hemolytic anemia in children 73
Esame emocromocitometrico 73
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation 72
Clinical and molecular evaluation of non-dominant hereditary spherocytosis 72
Terapia con rHu Epo in un caso di diabete mellito “early onset” ed anemia aplastica normocitica 72
Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments 71
Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients 70
Bilateral neuroretinitis in a 6-year-old boy with acquired toxoplasmosis 70
Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines:assessment of Italian experience 69
EVALUATION OF BODY IRON STATUS IN ITALIAN CARRIERS OF BETA-THALASSEMIA TRAIT 69
Clinical and biochemical study of thalassemia intermedia in Campania (southern Italy) 69
Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen 68
Totale 9.292
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021534 0 0 0 0 0 5 137 110 3 147 100 32
2021/2022763 96 8 7 18 257 7 13 19 27 72 66 173
2022/20231.814 144 40 27 205 206 176 3 134 804 13 33 29
2023/2024537 69 14 22 65 196 29 15 25 4 0 29 69
2024/20251.649 9 18 19 71 288 154 274 160 241 224 108 83
2025/20262.781 256 322 340 300 587 976 0 0 0 0 0 0
Totale 10.463